Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 61-72 of 1287 results.
"Low BMI and poor vascular morphology increase the risk of PICC-related thrombosis. The influence of BMI is likely mediated by vascular remodeling, with blood flow velocity peaking at 28.3 kg/m2 before declining, reflecting a compensatory hemodynamic balance" Wang et al (2025).
"The study aimed to investigate the epidemiology, microbial distribution, and predictors of 28-day mortality in CRBSI cases at a tertiary hospital from 2021 to 2023" Li et al (2025).
"The implementation of the CUIDAVEN mobile application was associated with a reduction in both infectious and non-infectious complications and improved adherence to recommended practices" Bujalance-Hoyos et al (2025).
"Subcutaneous tunneling for PICC placement is associated with a significant reduction in CLABSI rate among hospitalized adult patients" Shim et al (2025).
"Vertebral artery injury during central venous catheterization insertion is rare but can cause severe morbidity and mortality if not promptly recognized and managed" Alahmadi et al (2025).
"A hospital-wide BI system, combined with ID specialist expertise, was associated with a significant reduction in CRBSI incidence over time, especially in the high-risk ICU setting" Huang et al (2025).
"Significant variability in prevention and management of CA-DVT is reported among PC4 centers. Only half of respondent PC4 centers reported having an established treatment protocol for CA-DVT" Kim et al (2025).
"The primary objective of this study was to explore the relationship between compliance with national standards and PIVC-related sleep disturbance" Brijball et al (2025).
"Assuming universal real-time ultrasound-guided central venous catheterization, subclavian access retains lower infectious and thrombotic risk without an observed increase in mechanical complications, supporting its preferential use in intensive care units" Boulet et al (2025).
"To estimate the changes in total cost and health benefits associated with a decision to adopt 7-day vs standard 4-day replacement intervals via decision-analytic modeling" Elangovan et al (2025).
"OPAT was confirmed to be clinically robust and well tolerated, with additional potential benefits in preserving weight, frailty status, and cognitive well-being. These findings suggest that OPAT not only ensures infection control but may also protect against hospitalization-related functional decline" Ciusa et al (2025).
"Even peripheral IV cannulation may precipitate UEDVT when combined with local vein injury and systemic hypercoagulability. Antipsychotics, such as haloperidol and chlorpromazine, may further elevate thrombosis risk" Kwesiga et al (2025).
